Nautilus Biotechnology to Announce First Quarter 2025 Financial Results on April 29, 2025
Nautilus Biotechnology (NASDAQ: NAUT), a pioneer in single-molecule proteome analysis platform development, has scheduled its first quarter 2025 financial results announcement for Tuesday, April 29, 2025, before market open. The company will host a conference call and webcast at 5:30 a.m. Pacific Time / 8:30 a.m. Eastern Time to discuss quarterly results, business developments, and future outlook. Investors can access the live audio webcast through the company's website investor section at www.nautilus.bio.
Nautilus Biotechnology (NASDAQ: NAUT), pioniere nello sviluppo di piattaforme per l'analisi del proteoma a singola molecola, ha programmato l'annuncio dei risultati finanziari del primo trimestre 2025 per martedì 29 aprile 2025, prima dell'apertura dei mercati. L'azienda terrà una conference call e una webcast alle 5:30 a.m. ora del Pacifico / 8:30 a.m. ora dell'Est per discutere i risultati trimestrali, gli sviluppi aziendali e le prospettive future. Gli investitori potranno seguire la trasmissione audio in diretta attraverso la sezione investor del sito web aziendale www.nautilus.bio.
Nautilus Biotechnology (NASDAQ: NAUT), pionera en el desarrollo de plataformas para el análisis del proteoma a molécula única, ha programado el anuncio de sus resultados financieros del primer trimestre de 2025 para el martes 29 de abril de 2025, antes de la apertura del mercado. La compañía realizará una llamada de conferencia y una transmisión en vivo a las 5:30 a.m. hora del Pacífico / 8:30 a.m. hora del Este para discutir los resultados trimestrales, desarrollos comerciales y perspectivas futuras. Los inversores podrán acceder a la transmisión de audio en vivo a través de la sección para inversores en el sitio web de la compañía www.nautilus.bio.
Nautilus Biotechnology (NASDAQ: NAUT)는 단일 분자 프로테옴 분석 플랫폼 개발의 선구자로서, 2025년 1분기 재무 실적 발표를 2025년 4월 29일 화요일 시장 개장 전으로 예정했습니다. 회사는 태평양 표준시 오전 5시 30분 / 동부 표준시 오전 8시 30분에 분기 실적, 사업 현황 및 향후 전망에 대해 논의하는 컨퍼런스 콜과 웹캐스트를 진행할 예정입니다. 투자자들은 회사 웹사이트 투자자 섹션(www.nautilus.bio)을 통해 실시간 오디오 웹캐스트에 접속할 수 있습니다.
Nautilus Biotechnology (NASDAQ : NAUT), pionnier dans le développement de plateformes d'analyse du protéome à molécule unique, a programmé l'annonce de ses résultats financiers du premier trimestre 2025 pour le mardi 29 avril 2025, avant l'ouverture des marchés. La société organisera une conférence téléphonique et une webdiffusion à 5h30 heure du Pacifique / 8h30 heure de l'Est pour discuter des résultats trimestriels, des développements commerciaux et des perspectives d'avenir. Les investisseurs pourront accéder à la diffusion audio en direct via la section investisseurs du site web de la société www.nautilus.bio.
Nautilus Biotechnology (NASDAQ: NAUT), ein Pionier in der Entwicklung von Einzelmolekül-Proteomanalyseplattformen, hat die Bekanntgabe der Finanzergebnisse für das erste Quartal 2025 für Dienstag, den 29. April 2025, vor Börsenöffnung geplant. Das Unternehmen veranstaltet eine Telefonkonferenz und einen Webcast um 5:30 Uhr Pazifikzeit / 8:30 Uhr Ostküstenzeit, um die Quartalsergebnisse, Geschäftsentwicklungen und die zukünftige Perspektive zu besprechen. Investoren können den Live-Audio-Webcast über den Investor-Bereich der Unternehmenswebsite www.nautilus.bio verfolgen.
- None.
- None.
SEATTLE, April 16, 2025 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule proteome analysis platform, today announced it will report financial results for the first quarter 2025 before market open on Tuesday, April 29, 2025.
The company’s management will webcast a corresponding conference call beginning at 5:30 a.m. Pacific Time / 8:30 a.m. Eastern Time to discuss its results, business developments, and outlook. Live audio of the webcast will be available on the “Investors” section of the company website at: www.nautilus.bio.
About Nautilus Biotechnology, Inc.
With its corporate headquarters in Seattle, Washington and its research and development headquarters in San Carlos, California, Nautilus is a development stage life sciences company working to create a platform technology for quantifying and unlocking the complexity of the proteome. Nautilus’ mission is to transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. To learn more about Nautilus, visit www.nautilus.bio
Media Contact
press@nautilus.bio
Investor Contact
investorrelations@nautilus.bio
FAQ
When will Nautilus Biotechnology (NAUT) release Q1 2025 earnings?
What time is the NAUT Q1 2025 earnings conference call?
How can investors access Nautilus Biotechnology's Q1 2025 earnings call?
What will be discussed in NAUT's Q1 2025 earnings call?
